A phase 1 trial of BLU-5937 for chronic cough

Trial Profile

A phase 1 trial of BLU-5937 for chronic cough

Phase of Trial: Phase I

Latest Information Update: 11 Aug 2017

At a glance

  • Drugs BLU-5937 (Primary)
  • Indications Cough
  • Focus Adverse reactions
  • Most Recent Events

    • 11 Aug 2017 New trial record
    • 09 Aug 2017 According to a BELLUS Health media release, the company is planning file an IND application in 2018 and initiate this trial in the second half of 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top